Physician profile
Bassem Mikhail
NPI 1932189735
$20,658.28
in general payments reported to CMS, 2019-2025
39 companies · $1,309 in 2025
The $1,309 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,784 · 2020: $1,180 · 2021: $3,025 · 2022: $5,002 · 2023: $1,924 · 2024: $2,434 · 2025: $1,309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,598 · Travel and Lodging: $980 · Education: $88.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,597.54 |
| Travel and Lodging | $980.23 |
| Education | $88.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $5,082.78 | 2019-2023 | Impella |
| Philips North America LLC | $3,980.90 | 2019-2025 | Igt Devices Undivided, Epiq Cvx, (Az7) Lasers |
| Medtronic, INC. | $2,806.57 | 2021-2025 | Onyx Frontier, Symplicity G3, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $1,070.94 | 2019-2025 | Diamondback Coronary, Jot Dx, Amplatzer Talisman |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,061.22 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $1,047.27 | 2019-2020 | |
| Shockwave Medical, INC | $727.25 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $584.07 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $559.93 | 2019-2025 | Cds - Mct/Cem Monitoring, Synergy, General - Tachy |
| Novartis Pharmaceuticals Corporation | $537.95 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $476.55 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $385.71 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals Lp | $360.77 | 2019-2022 | |
| Pfizer INC. | $270.53 | 2019-2024 | |
| Penumbra, INC. | $261.97 | 2021-2023 | Indigo System |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $259.12 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $148.72 | 2022-2025 | |
| Biotronik INC. | $136.41 | 2020-2022 | |
| Cardiovascular Systems INC. | $134.95 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $132.64 | 2022-2025 | Uptravi, Opsumit |
| Merck Sharp & Dohme LLC | $80.57 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $80.01 | 2019-2023 | |
| Kiniksa Pharmaceuticals, Ltd. | $66.29 | 2023 | Arcalyst |
| Edwards Lifesciences Corporation | $59.47 | 2019-2022 | |
| Inari Medical, INC. | $44.64 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amarin Pharma, INC. | $43.54 | 2019-2022 | |
| Angiodynamics, INC. | $35.48 | 2023 | Auryon Laser System 100-120 Vac |
| Cvrx, INC. | $30.40 | 2024 | Barostim Neo System |
| Esperion Therapeutics, INC. | $27.37 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $23.49 | 2019 | |
| Zoll Circulation INC | $22.63 | 2025 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| United Therapeutics Corporation | $20.25 | 2019 | |
| Novo Nordisk INC | $15.95 | 2025 | Wegovy |
| Irhythm Technologies, INC. | $15.29 | 2020 | |
| Cook Medical LLC | $14.69 | 2023 | Zilver Ptx |
| Impulse Dynamics (USA) INC. | $13.50 | 2025 | Optimizer |
| Scpharmaceuticals INC. | $13.39 | 2024 | |
| Janssen Scientific Affairs, LLC | $12.84 | 2023 | Xarelto |
| Kowa Pharmaceuticals America, INC. | $12.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bassem Mikhail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.